Dean Tozer insider trades: Cytomedix (CMXI) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Dean reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 6, 2014 | CMXI | ↑ Buy | 33,300 | $0.36 | $12K | Direct | Oct 8, 2014 (2d) |
| Sep 12, 2014 | CMXI | ↑ Buy | 40,000 | $0.45 | $18K | Direct | Sep 16, 2014 (4d) |
| Aug 29, 2014 | CMXI | ↑ Buy | 40,000 | $0.35 | $14K | Direct | Sep 2, 2014 (4d) |
| Aug 22, 2014 | CMXI | ↑ Buy | 38,700 | $0.38 | $15K | Direct | Aug 25, 2014 (3d) |
| Aug 20, 2014 | CMXI | ↑ Buy | 48,000 | $0.39 | $19K | Direct | Aug 21, 2014 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Dean Tozer's insider trades
Dean Tozer is Chief Commercial Officer at Cytomedix (CMXI). Since Aug 20, 2014, Dean has reported 5 open-market purchases worth $77K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CMXI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.